Combination therapy with docetaxel plus fluorouracil is active in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Docetaxel Plus 5-Fluorouracil in Locally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000136017.13633.b0 ◽

2004 ◽

Vol 27 (5) ◽

pp. 472-476 ◽

Cited By ~ 16

Author(s):

Dominique Genet ◽

D Cupissol ◽

G Calais ◽

P Bontemps ◽

H Bourgeois ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase II Trial of Interferon-?? in Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Immunological and Clinical Correlates

Journal of Immunotherapy ◽

10.1097/00002371-199611000-00008 ◽

1996 ◽

Vol 19 (6) ◽

pp. 433-442 ◽

Cited By ~ 23

Author(s):

Daniel R. Vlock ◽

Janet Andersen ◽

Leslie A. Kalish ◽

Jonas T. Johnson ◽

John M. Kirkwood ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Clinical Correlates ◽

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Faculty Opinions recommendation of Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734912521.793555705 ◽

2019 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Second Line ◽

MO3-2 Prognostic significance of metastatic sites in recurrent or metastatic squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1016/j.annonc.2021.05.565 ◽

2021 ◽

Vol 32 ◽

pp. S296

Author(s):

Ari Nishimura ◽

Tomoya Yokota ◽

Yoshiyuki Iida ◽

Tomoyuki Kamijo ◽

Takashi Mukaigawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Prognostic Significance ◽

Metastatic Sites

A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix

European Journal of Cancer ◽

10.1016/j.ejca.2004.12.013 ◽

2005 ◽

Vol 41 (4) ◽

pp. 523-530 ◽

Cited By ~ 65

Author(s):

Jennifer J. Knox ◽

Lillian L. Siu ◽

Eric Chen ◽

Jim Dimitroulakos ◽

Suzanne Kamel-Reid ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Prolonged Administration ◽

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck

Head & Neck ◽

10.1002/hed.25636 ◽

2019 ◽

Vol 41 (6) ◽

pp. 1895-1902 ◽

Cited By ~ 1

Author(s):

Aurora Mirabile ◽

Rosalba Miceli ◽

Rosa Gioia Calderone ◽

Laura Locati ◽

Paolo Bossi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Re-irradiation with concurrent and maintenance Nivolumab in locally recurrent and inoperable Squamous Cell Carcinoma of the Head and Neck: a single-center cohort study

Clinical and Translational Radiation Oncology ◽

10.1016/j.ctro.2021.03.004 ◽

2021 ◽

Author(s):

Alev Altay-Langguth ◽

Panagiotis Balermpas ◽

Christian Brandts ◽

Sven Balster ◽

Shahram Ghanaati ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cohort Study ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Single Center ◽